GMED | tickerfilter.com

Fundamental analysis

35%

Profitability 39%

Dept financing 33%

Liquidity 56%

Performance 26%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.90%

1 Month

2.39%

3 Months

9.18%

6 Months

33.49%

1 Year

31.35%

2 Year

22.95%

Key data

Stock price

$72.70

P/E Ratio

242.02

DAY RANGE

$71.88 - $72.79

EPS

$0.31

52 WEEK RANGE

$43.39 - $74.21

52 WEEK CHANGE

$0.34

MARKET CAP

9.844 B

YIELD

N/A

SHARES OUTSTANDING

135.407 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/05/2024

BETA

0.85

PUBLIC FLOAT

AVERAGE 10 VOLUME

$561,636

AVERAGE 30 VOLUME

$1,069,354

Company detail

CEO: David Demski
Region: US
Website: http://www.globusmedical.com/
Employees: 2,112
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

GMED - Globus Medical Inc - Ordinary Shares - Class A